Strahlentherapie spinaler Tumoren

Zusammenfassung

Die Behandlung maligner Erkrankungen der Wirbelsäule ist grundsätzlich multidiziplinär angelegt. In vielen Fällen wird daher nach einer Operation, in Einzelfällen auch neoadjuvant oder als Alternative zur Operation, eine Strahlentherapie diskutiert. Die vorliegende Arbeit soll die Möglichkeiten, die Wirksamkeit und auch die Grenzen der modernen Radioonkologie aufzeigen. Dabei werden die typischen Indikationen zur Strahlentherapie besprochen und die zu erwartende Prognose und evtl. auftretende Nebenwirkungen besprochen. Weiterhin wird auf die Wechselwirkungen zwischen der operativen Versorgung inklusive der verwendeten Implantate und der sich anschließenden Bestrahlung eingegangen.

Abstract

The treatment of malignant diseases of the spine is multidisciplinary. In the majority of cases, radiotherapy is discussed as adjuvant treatment after surgery, in individual cases neoadjuvant or definitive treatment is taken into consideration. The present work shows the possibilities, effectiveness and limitations of modern radiotherapy. The typical indications for radiotherapy at the spine are discussed and the expected prognosis and side effects are explained. Furthermore, the interactions between surgery, including the physical aspects of the implanted devices and the subsequent irradiation are discussed.

Schlüsselwörter

Spinale Metastasen - Strahlentherapie - Körperstereotaxie - PEEK - Carbonfaser

Keywords

Spinal metastases - Radiotherapy - SBRT; PEEK - Carbonfibre

• Literatur

• 1 Herrmann T, Baumann M, Dörr W. Klinische Strahlenbiologie 4. Auflage. Urban & Fischer Verlag/Elsevier GmbH; 2006
• 2 Wannenmacher M, Wenz F, Debus J. Strahlentherapie. Berlin, Heidelberg: Springer Berlin Heidelberg; 2013
• 3 Song CW, Glatstein E, Marks LB. et al. Biological Principles of Stereotactic Body Radiation Therapy (SBRT) and Stereotactic Radiation Surgery (SRS): Indirect Cell Death. Int J Radiat Oncol 2019;
• 4 Jabbari S, Gerszten PC, Ruschin M. et al. Stereotactic body radiotherapy for spinal metastases: Practice guidelines, outcomes, and risks. Cancer J (United States) 2016; 22: 280-289
• 5 Schaub SK, Tseng YD, Chang EL. et al. Strategies to Mitigate Toxicities From Stereotactic Body Radiation Therapy for Spine Metastases. Neurosurgery 2019; 0: 1-12
• 6 Lutz S, Balboni T, Jones J. et al. Palliative radiation therapy for bone metastases: Update of an ASTRO Evidence-Based Guideline. Pract Radiat Oncol 2017; 7: 4-12
• 7 Straube C, Oechsner M, Kampfer S. et al. Dosimetric impact of tumor treating field (TTField) transducer arrays onto treatment plans for glioblastomas – a planning study. Radiat Oncol 2018; 13: 31
• 8 Jia Y, Zhao L, Cheng C. et al. Dose Perturbation of Spinal Metal Implants in Proton Beam Therapy. Med Phys 2013; 40: 309
• 9 Verburg JM, Seco J. Dosimetric accuracy of proton therapy for chordoma patients with titanium implants. Med Phys 2013; 40: 1-13
• 10 Mastella E, Molinelli S, Magro G. et al. Dosimetric characterization of carbon fiber stabilization devices for post-operative particle therapy. Phys Medica 2017; 44: 18-25
• 11 Meeuse JJ, Van Der Linden YM, Van Tienhoven G. et al. Efficacy of radiotherapy for painful bone metastases during the last 12 weeks of life: Results from the dutch bone metastasis study. Cancer 2010; 116: 2716-2725
• 12 Grosu AL, Nieder C. Target Volume Definition in Radiation Oncology. Berlin, Heidelberg: Springer Berlin Heidelberg; 2015
• 13 Chow E, Zeng L, Salvo N. et al. Update on the Systematic Review of Palliative Radiotherapy Trials for Bone Metastases. Clin Oncol 2012; 24: 112-124
• 14 Rose PS, Laufer I, Boland PJ. et al. Risk of fracture after single fraction image-guided intensity-modulated radiation therapy to spinal metastases. J Clin Oncol 2009; 27: 5075-5079
• 15 Chow E, van der Linden YM, Roos D. et al. Single versus multiple fractions of repeat radiation for painful bone metastases: A randomised, controlled, non-inferiority trial. Lancet Oncol 2014; 15: 164-171
• 16 Schaub SK, Tseng YD, Chang EL. et al. Strategies to Mitigate Toxicities From Stereotactic Body Radiation Therapy for Spine Metastases. Neurosurgery 2019; 85: 1-12
• 17 Bludau F, Welzel G, Reis T. et al. Combined kyphoplasty and intraoperative radiotherapy (Kypho-IORT) versus external beam radiotherapy (EBRT) for painful vertebral metastases – A randomized phase III study. BMC Cancer 2019; 19: 1-7
• 18 Patchell RA, Tibbs PA, Regine WF. et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: A randomised trial. Lancet 2005; 366: 643-648
• 19 Rades D, Šegedin B, Conde-Moreno AJ. et al. Radiotherapy with 4 Gy × 5 versus 3 Gy × 10 for metastatic epidural spinal cord compression: Final results of the SCORE-2 Trial (ARO 2009/01). J Clin Oncol 2016; 34: 597-602
• 20 Sprave T, Hees K, Bruckner T. et al. The influence of fractionated radiotherapy on the stability of spinal bone metastases: A retrospective analysis from 1047 cases. Radiat Oncol 2018; 13: 1-9
• 21 Bostel T, Förster R, Schlampp I. et al. Stability and survival analysis of elderly patients with osteolytic spinal bone metastases after palliative radiotherapy: Results from a large multicenter cohort. Strahlentherapie und Onkol 2019;
• 22 Rudzianskiene M, Inciura A, Gerbutavicius R. et al. Einzelne Fraktion vs. multiple Fraktionen in der palliativen Strahlentherapie des multiplen Myeloms: Eine prospektive randomisierte Studie. Strahlentherapie und Onkol 2017; 193: 742-749
• 23 Spratt DE, Beeler WH, de Moraes FY. et al. An integrated multidisciplinary algorithm for the management of spinal metastases: an International Spine Oncology Consortium report. Lancet Oncol 2017; 18: e720-e730
• 24 Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol 1995; 13: 8-10
• 25 Weichselbaum RR. The 46th David A. Karnofsky Memorial Award Lecture: Oligometastasis—From Conception to Treatment. J Clin Oncol 2018; 36
• 26 Stacchiotti S, Sommer J. Building a global consensus approach to chordoma: a position paper from the medical and patient community on behalf of a Chordoma global consensus group*. Lancet Oncol 2015; 16: 71-83
• 27 Jiang B, Veeravagu A, Lee M. et al. Management of intracranial and extracranial chordomas with CyberKnife stereotactic radiosurgery. J Clin Neurosci 2012; 19: 1101-1106
• 28 Fourney DR, Frangou EM, Ryken TC. et al. Spinal instability neoplastic score: An analysis of reliability and validity from the spine Oncology Study Group. J Clin Oncol 2011; 29: 3072-3077